SEC Form 4 · accession 0001552781-16-001952
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Spitznagel
Officer — Sr VP, BPD & Manufacturing
Period of report
Sep 14, 2016
Accepted (ET)
Sep 16, 2016 · 6:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $28.94 | Sep 14, 2016 | A | 20,000 | A | — | Sep 14, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F112.5% of the option becomes exercisable on March 14, 2017 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter.